Pipeline — registered trials by phase
A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme
— · Weight Gain · Completed
Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic Treatment
— · Schizophrenia · Completed
Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)
— · Diabetes Mellitus, Type 2 · Completed · est. 2009-03
Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo
— · Osteoporosis, Post-Menopausal · Completed
Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes
— · Attention-Deficit/Hyperactivity Disorder · Completed
A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture
— · Osteoporosis · Completed · est. 2015-08
Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia
— · Depression, Schizophrenia, Schizoaffective Disorder · Completed
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
— · Depression · Completed · est. 2009-02
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
— · Osteoporosis, Postmenopausal · Completed
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
— · Diabetes Mellitus, Type 2 · Completed · est. 2025-09-02
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DC-853 in Healthy Participants
— · Healthy · Completed · est. 2023-10-30
A Study of LY3209590 in Japanese Participants With Type 2 Diabetes Mellitus
— · Diabetes Mellitus, Type 2 · Completed · est. 2020-11-28
A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
— · Diabetes Mellitus, Type 1 · Completed · est. 2023-03-07
A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
— · Obesity · Completed · est. 2023-02-24
A Bioavailability Study of LY2452473 and Tadalafil
— · Erectile Dysfunction · Completed · est. 2011-09
A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
— · Diabetes Mellitus, Type 1 · Completed · est. 2020-07-14
Notch Inhibitor in Advanced Cancer
— · Advanced Cancer · Completed · est. 2012-08
A Phase 1 Study in Participants With Advanced Cancer
— · Advanced Cancer, Squamous Cell Carcinoma, Carcinoma, Squamous Cell of Head and Neck · Completed · est. 2016-01
A Safety Study of LY3372689 Given By Mouth to Healthy Participants
— · Healthy · Completed · est. 2019-06-23
A Study of LY3832479 (LY-CoV016) in Healthy Participants
— · Healthy · Completed · est. 2020-10-02
A Study of LY4515100 in Healthy Participants
— · Healthy · Recruiting · est. 2027-03
Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors
— · Malignancy, Metastasis · Completed · est. 2012-01
A Study of LY3337641 in Japanese and Caucasian Healthy Participants
— · Healthy · Completed · est. 2017-05-25
A Study of LY3532226 in Participants With Type 2 Diabetes Mellitus
— · Diabetes Mellitus, Type 2 · Completed · est. 2024-01-12
A Study of LY3866288 in Healthy Participants
— · Healthy · Completed · est. 2024-12-02
A Study of LY2886721 in Healthy Participants
— · Healthy Volunteers · Completed · est. 2012-07
A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers
— · Bipolar Disorder · Completed · est. 2011-05
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
— · Type 1 Diabetes Mellitus · Completed · est. 2019-11-14
A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants
— · Healthy · Completed · est. 2024-04-01
A Study of Evacetrapib and Rifampin in Healthy Participants
— · Healthy Volunteers · Completed · est. 2013-09
A Study of Abemaciclib in Healthy Participants
— · Healthy · Completed · est. 2016-10
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
— · Soft Tissue Sarcoma · Completed · est. 2019-04-29
A Study of Multiple Increasing Doses of LY2409021 in Participants With Type 2 Diabetes
— · Diabetes Mellitus, Type 2 · Completed · est. 2008-11
A Study of LY2624803 in Participants With Transient Insomnia
— · Transient Insomnia · Completed · est. 2008-11
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
— · Obesity · Completed · est. 2022-05-26
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus
— · Type 2 Diabetes Mellitus · Completed · est. 2018-08-01
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
— · Inflammatory Bowel Diseases, Colitis, Ulcerative · Active Not Recruiting · est. 2024-11-28
First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
— · Non-Small Cell Lung Cancer · Completed · est. 2009-07
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
— · Nonalcoholic Steatohepatitis · Completed · est. 2023-12-11
A Study for Participants With Type 2 Diabetes Mellitus
— · Diabetes Mellitus, Type 2 · Completed · est. 2010-02
A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
— · Advanced Gastric Carcinoma · Completed
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
— · Endometrial Cancer · Completed
JAK Inhibitor Treatment in AGS
— · Aicardi Goutieres Syndrome · Completed · est. 2024-01-04
Combination Chemotherapy for Metastatic Breast Cancer
— · Breast Cancer · Completed
A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer
— · Metastatic Breast Cancer · Completed · est. 2012-03
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
— · Metastatic Breast Cancer · Completed · est. 2016-04-30
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
— · Asthma · Recruiting · est. 2028-04
A Study in Non Small Cell Lung Cancer
— · Non Small Cell Lung Cancer · Completed · est. 2013-05
A Study for Participants With Metastatic Renal Cell Carcinoma
— · Metastatic Renal Cell Carcinoma · Completed · est. 2010-02-15
A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy
— · Rheumatoid Arthritis · Completed · est. 2010-01
A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma
— · Waldenstrom's Macroglobulinemia, Multiple Myeloma · Completed · est. 2010-09
Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer
— · Breast Cancer, Neoplasm Metastasis · Completed
A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
— · Urologic Neoplasms · Completed
Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
— · Coronary Arteriosclerosis, Acute Coronary Syndrome · Completed · est. 2008-12
Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia
— · Benign Prostatic Hyperplasia · Completed · est. 2010-06
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
— · Overweight, Obesity · Recruiting · est. 2028-06
The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death
— · Sepsis · Completed
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
— · Psoriasis, Obesity · Completed · est. 2026-01-08
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
— · Diabetes Type 2, Diabetes Mellitus, Glucose Metabolism Disorders · Completed · est. 2024-07-01
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
— · Diabetes Mellitus, Type 2 · Completed · est. 2019-05-28
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
— · Diabetic Neuropathies, Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Non-Insulin-Dependent · Completed
A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT Trial
— · Obesity, Heart Failure With Preserved Ejection Fraction (HFpEF) · Completed · est. 2024-07-02
Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin
— · Type 2 Diabetes Mellitus · Completed
A Phase III Trial For Patients With Metastatic Breast Cancer
— · Breast Cancer, Breast Neoplasms, Cancer of the Breast · Completed · est. 2008-11
Duloxetine Versus Placebo in Chronic Low Back Pain
— · Back Pain Without Radiation · Completed · est. 2007-11
A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis
— · Spondyloarthritis · Completed · est. 2021-03-31
Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression
— · Major Depressive Disorder · Completed
Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion
— · Sepsis, Hypotension · Completed
A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
— · Type 1 Diabetes Mellitus · Completed · est. 2021-07-02
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities
— · Obesity, Overweight · Completed · est. 2024-11-13
A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
— · Type 2 Diabetes · Completed · est. 2021-01-28
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Eli Lilly is lead sponsor; 81 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- SCHEDULE 13D2026-07-30SCHEDULE 13D
- SCHEDULE 13G/A2026-07-24SCHEDULE 13G/A
- SCHEDULE 13G2026-07-24SCHEDULE 13G
- SCHEDULE 13G/A2026-07-23SCHEDULE 13G/A
- 11-K2026-06-2311-K
- 25-NSE2026-06-0225-NSE
- 8-K2026-05-20Current report (material event)
- SD2026-05-11SD
- 424B22026-05-08424B2
- 8-K2026-05-07Current report (material event)
- FWP2026-05-06FWP
- 424B22026-05-06424B2
- SCHEDULE 13G2026-05-01SCHEDULE 13G
- 10-Q2026-04-30Quarterly report
- 8-K2026-04-30Current report (material event)
- PX14A6G2026-04-29PX14A6G
- SCHEDULE 13G/A2026-04-20SCHEDULE 13G/A
- DFAN14A2026-03-31DFAN14A
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- DEFA14A2026-03-20DEFA14A
- DEF 14A2026-03-20Proxy statement
- PRE 14A2026-03-06PRE 14A
- 10-K2026-02-12Annual report
- 8-K2026-02-04Current report (material event)
- SCHEDULE 13G/A2026-01-23SCHEDULE 13G/A
- SCHEDULE 13D2026-01-15SCHEDULE 13D
- SC TO-T/A2025-12-09SC TO-T/A
- 8-K2025-11-21Current report (material event)
- SC TO-T2025-11-07SC TO-T
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- 10-Q2025-10-30Quarterly report
- 8-K2025-10-30Current report (material event)
- SC TO-C2025-10-24SC TO-C
- SCHEDULE 13G/A2025-10-03SCHEDULE 13G/A
- 8-K2025-08-20Current report (material event)
- 424B22025-08-19424B2
- FWP2025-08-18FWP
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.